Emad Ibrahim, MD, Inc. is a clinical research site located in Redlands, California, United States 92373.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Emad Ibrahim, MD, Inc. has participated in 6 clinical trials with 4 currently active.
Therapeutic areas: Myelodysplastic Syndromes, Advanced Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer.
Sponsors: Agios Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Spectrum Pharmaceuticals, Inc.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Emad Ibrahim, MD, Inc. has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Emad Ibrahim, MD, Inc. has 6 clinical trials on record, with 4 currently active. Their work covers Myelodysplastic Syndromes, Advanced Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer.
Yes — Emad Ibrahim, MD, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.